Indi Molecular's Series A Round

Indi Molecular raised a round of funding on June 20, 2017.

Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. PCCs were…

Articles about Indi Molecular's Series A Round: